2045-1253

Therapeutic Advances in Psychopharmacology

SAGE Publications

View prefix report (10.1177)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 307 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact307 DOIs
2

Add abstracts to 100 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact100 DOIs
3

Deposit reference lists for 50 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact50 DOIs

DOIs for this ISSN

Showing the top 5 of 627 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Naming the drugs we use: neuroscience-based nomenclature, a… (10.1177/2045125318762065)
Abstract References ORCID
78.10 10
2 Medication adherence in schizophrenia: factors influencing a… (10.1177/2045125312474019)
ORCID
67.05 480
3 Cannabis, a complex plant: different compounds and different… (10.1177/2045125312457586)
ORCID
66.83 470
4 Unexpected effect of aripiprazole on nociceptive pain (10.1177/2045125312451271)
Abstract ORCID
63.94 18
5 Agomelatine and migraine management: a successfully treated… (10.1177/2045125315584869)
Abstract ORCID
62.76 17
6 Clozapine withdrawal emergent dystonia, oculogyric crisis an… (10.1177/2045125315591928)
Abstract ORCID
61.52 16
7 The role of long-acting injectable antipsychotics in schizop… (10.1177/2045125314540297)
ORCID
60.08 252
8 Antidepressive, anxiolytic, and antiaddictive effects of aya… (10.1177/2045125316638008)
ORCID
59.51 239
9 The acute efficacy of antipsychotics in schizophrenia: a rev… (10.1177/2045125318781475)
ORCID
58.80 224
10 Perverse effects of the precautionary principle: how banning… (10.1177/2045125311406958)
Abstract ORCID
57.31 13
11 Serotonin syndrome with a combination of aripiprazole and fl… (10.1177/2045125314561467)
Abstract ORCID
57.31 13
12 The drugs don’t work? antidepressants and the current and fu… (10.1177/2045125312445469)
ORCID
56.20 176
13 Bupropion: a systematic review and meta-analysis of effectiv… (10.1177/2045125316629071)
ORCID
55.95 172
14 Frontotemporal dementia: latest evidence and clinical implic… (10.1177/2045125317739818)
ORCID
54.90 156
15 Clozapine-related EEG changes and seizures: dose and plasma-… (10.1177/2045125311405566)
ORCID
54.03 144
16 Case report of a switch to mania induced by lurasidone (10.1177/2045125316677954)
Abstract ORCID
53.96 11
17 Ayahuasca, dimethyltryptamine, and psychosis: a systematic r… (10.1177/2045125316689030)
ORCID
53.65 139
18 Lithium: the pharmacodynamic actions of the amazing ion (10.1177/2045125312471963)
ORCID
52.25 122
19 Psychosis during treatment with isotretinoin (10.1177/2045125312470129)
Abstract ORCID
52.07 10
20 Drug models of schizophrenia (10.1177/2045125314557797)
ORCID
51.98 119
21 Ketamine as the prototype glutamatergic antidepressant: phar… (10.1177/2045125313507739)
ORCID
51.89 118
22 Brexpiprazole and cariprazine: distinguishing two new atypic… (10.1177/2045125316672136)
ORCID
51.42 113
23 Psychiatric manifestations in Wilson’s disease: possibilitie… (10.1177/2045125318759461)
ORCID
51.42 113
24 Classical hallucinogens as antidepressants? A review of phar… (10.1177/2045125314527985)
ORCID
50.63 105
25 Legal highs: staying on top of the flood of novel psychoacti… (10.1177/2045125314559539)
ORCID
50.63 105
26 Neonatal hypoglycaemia following maternal olanzapine therapy… (10.1177/2045125312460395)
Abstract ORCID
50.00 9
27 The prevalence and mechanisms of metabolic syndrome in schiz… (10.1177/2045125312464385)
ORCID
50.00 99
28 Memantine in the management of affective recurrences of bipo… (10.1177/2045125313507737)
Abstract ORCID
50.00 9
29 Plasma 1,8-cineole correlates with cognitive performance fol… (10.1177/2045125312436573)
ORCID
49.89 98
30 Lactate in the brain: an update on its relevance to brain en… (10.1177/2045125316675579)
ORCID
49.78 97
31 Acute and chronic cognitive effects of levodopa and dopamine… (10.1177/2045125312470130)
ORCID
49.33 93
32 New avenues for treating emotional memory disorders: towards… (10.1177/2045125316644541)
ORCID
49.21 92
33 Ketamine enantiomers in the rapid and sustained antidepressa… (10.1177/2045125316631267)
ORCID
48.36 85
34 The role of selective serotonin reuptake inhibitors in preve… (10.1177/2045125317737264)
ORCID
48.11 83
35 Genetic risk factors for eating disorders: an update and ins… (10.1177/2045125318814734)
ORCID
48.11 83
36 Ziprasidone for obsessive compulsive disorder in schizophren… (10.1177/2045125312467347)
Abstract ORCID
47.71 8
37 A review of the management of antidepressant discontinuation… (10.1177/2045125315612334)
ORCID
47.71 80
38 Brexpiprazole: so far so good (10.1177/2045125315614739)
ORCID
46.88 74
39 Plasma prolactin and bone mineral density in patients on lon… (10.1177/2045125312464996)
Abstract References ORCID
45.15 3
40 Hypothermia in a patient with Alzheimer’s disease receiving… (10.1177/2045125315591916)
Abstract ORCID
45.15 7
41 Interaction between clozapine and oxcarbazepine: a case repo… (10.1177/2045125316681472)
Abstract ORCID
45.15 7
42 A stitch in time: 3-monthly long-acting injectable paliperid… (10.1177/2045125317721874)
Abstract ORCID
45.15 7
43 The prospects of cariprazine in the treatment of schizophren… (10.1177/2045125317727260)
Abstract ORCID
45.15 7
44 Hallucinogen-persisting perception disorder (10.1177/2045125312451270)
ORCID
44.81 61
45 Clozapine prescribing in the UK: views and experience of con… (10.1177/2045125314566808)
ORCID
44.63 60
46 Correlation between total vitamin D levels and psychotic psy… (10.1177/2045125314553612)
ORCID
44.27 58
47 Quetiapine, QTc interval prolongation, and… (10.1177/2045125313510194)
ORCID
44.09 57
48 Anti-cytokine agents for anhedonia: targeting inflammation a… (10.1177/2045125318791944)
ORCID
44.09 57
49 Transdermal patches: the emerging mode of drug delivery syst… (10.1177/2045125312458311)
ORCID
43.90 56
50 Clozapine-induced hypersalivation: an estimate of prevalence… (10.1177/2045125316641019)
ORCID
43.70 55